1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America
Abstract
This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideli …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
Child
neoplasms / drug therapy
time factors
drug therapy
neutropenia / complications*
practice guideline
antineoplastic agents / adverse effects
fever of unknown origin / drug therapy*
neutropenia / chemically induced
guideline
neutropenia / drug therapy*
bacterial infections / complications
combination / therapeutic use
anti-bacterial agents / therapeutic use*
anti-bacterial agents / economics
cost-benefit analysis
bacterial infections / drug therapy
antiviral agents / therapeutic use
pmid:9314442
doi:10.1086/513764
w t hughes
d armstrong
l s young
colony-stimulating factors / therapeutic use
fever of unknown origin / complications*
granulocytes / transplantation
Access
Citation
ID:
115513
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115513
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet